世界の深部静脈血栓症（DVT）治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Deep Vein Thrombosis (DVT) Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1746 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、深部静脈血栓症（DVT）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗凝血剤、組織プラスミノーゲン活性化因子、その他薬剤）、用途別市場規模（病院、クリニック、ドラッグストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・深部静脈血栓症（DVT）治療薬の市場動向 ・企業の競争状況、市場シェア ・深部静脈血栓症（DVT）治療薬の種類別市場規模（抗凝血剤、組織プラスミノーゲン活性化因子、その他薬剤） ・深部静脈血栓症（DVT）治療薬の用途別市場規模（病院、クリニック、ドラッグストア） ・深部静脈血栓症（DVT）治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・深部静脈血栓症（DVT）治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・深部静脈血栓症（DVT）治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・深部静脈血栓症（DVT）治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・深部静脈血栓症（DVT）治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer、Bristol-Myers Squibb、Pfizer、Sanofi、GSK、Daiichi Sankyo） ・結論

Market Analysis and Insights: Global Deep Vein Thrombosis (DVT) Drug Market
The global Deep Vein Thrombosis (DVT) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Deep Vein Thrombosis (DVT) Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Deep Vein Thrombosis (DVT) Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Deep Vein Thrombosis (DVT) Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Deep Vein Thrombosis (DVT) Drug market.

Global Deep Vein Thrombosis (DVT) Drug Scope and Market Size
Deep Vein Thrombosis (DVT) Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Deep Vein Thrombosis (DVT) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Blood Thinners
Tissue Plasminogen Activators
Other Drug

Segment by Application
Hospitals
Clinics
Drug Stores

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer
Bristol-Myers Squibb
Pfizer
Sanofi
GSK
Daiichi Sankyo

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Deep Vein Thrombosis (DVT) Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood Thinners
1.2.3 Tissue Plasminogen Activators
1.2.4 Other Drug
1.3 Market by Application
1.3.1 Global Deep Vein Thrombosis (DVT) Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drug Stores
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Deep Vein Thrombosis (DVT) Drug Market Perspective (2016-2027)
2.2 Deep Vein Thrombosis (DVT) Drug Growth Trends by Regions
2.2.1 Deep Vein Thrombosis (DVT) Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Deep Vein Thrombosis (DVT) Drug Historic Market Share by Regions (2016-2021)
2.2.3 Deep Vein Thrombosis (DVT) Drug Forecasted Market Size by Regions (2022-2027)
2.3 Deep Vein Thrombosis (DVT) Drug Industry Dynamic
2.3.1 Deep Vein Thrombosis (DVT) Drug Market Trends
2.3.2 Deep Vein Thrombosis (DVT) Drug Market Drivers
2.3.3 Deep Vein Thrombosis (DVT) Drug Market Challenges
2.3.4 Deep Vein Thrombosis (DVT) Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Deep Vein Thrombosis (DVT) Drug Players by Revenue
3.1.1 Global Top Deep Vein Thrombosis (DVT) Drug Players by Revenue (2016-2021)
3.1.2 Global Deep Vein Thrombosis (DVT) Drug Revenue Market Share by Players (2016-2021)
3.2 Global Deep Vein Thrombosis (DVT) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Deep Vein Thrombosis (DVT) Drug Revenue
3.4 Global Deep Vein Thrombosis (DVT) Drug Market Concentration Ratio
3.4.1 Global Deep Vein Thrombosis (DVT) Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Deep Vein Thrombosis (DVT) Drug Revenue in 2020
3.5 Deep Vein Thrombosis (DVT) Drug Key Players Head office and Area Served
3.6 Key Players Deep Vein Thrombosis (DVT) Drug Product Solution and Service
3.7 Date of Enter into Deep Vein Thrombosis (DVT) Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Deep Vein Thrombosis (DVT) Drug Breakdown Data by Type
4.1 Global Deep Vein Thrombosis (DVT) Drug Historic Market Size by Type (2016-2021)
4.2 Global Deep Vein Thrombosis (DVT) Drug Forecasted Market Size by Type (2022-2027)

5 Deep Vein Thrombosis (DVT) Drug Breakdown Data by Application
5.1 Global Deep Vein Thrombosis (DVT) Drug Historic Market Size by Application (2016-2021)
5.2 Global Deep Vein Thrombosis (DVT) Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Deep Vein Thrombosis (DVT) Drug Market Size (2016-2027)
6.2 North America Deep Vein Thrombosis (DVT) Drug Market Size by Type
6.2.1 North America Deep Vein Thrombosis (DVT) Drug Market Size by Type (2016-2021)
6.2.2 North America Deep Vein Thrombosis (DVT) Drug Market Size by Type (2022-2027)
6.2.3 North America Deep Vein Thrombosis (DVT) Drug Market Size by Type (2016-2027)
6.3 North America Deep Vein Thrombosis (DVT) Drug Market Size by Application
6.3.1 North America Deep Vein Thrombosis (DVT) Drug Market Size by Application (2016-2021)
6.3.2 North America Deep Vein Thrombosis (DVT) Drug Market Size by Application (2022-2027)
6.3.3 North America Deep Vein Thrombosis (DVT) Drug Market Size by Application (2016-2027)
6.4 North America Deep Vein Thrombosis (DVT) Drug Market Size by Country
6.4.1 North America Deep Vein Thrombosis (DVT) Drug Market Size by Country (2016-2021)
6.4.2 North America Deep Vein Thrombosis (DVT) Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Deep Vein Thrombosis (DVT) Drug Market Size (2016-2027)
7.2 Europe Deep Vein Thrombosis (DVT) Drug Market Size by Type
7.2.1 Europe Deep Vein Thrombosis (DVT) Drug Market Size by Type (2016-2021)
7.2.2 Europe Deep Vein Thrombosis (DVT) Drug Market Size by Type (2022-2027)
7.2.3 Europe Deep Vein Thrombosis (DVT) Drug Market Size by Type (2016-2027)
7.3 Europe Deep Vein Thrombosis (DVT) Drug Market Size by Application
7.3.1 Europe Deep Vein Thrombosis (DVT) Drug Market Size by Application (2016-2021)
7.3.2 Europe Deep Vein Thrombosis (DVT) Drug Market Size by Application (2022-2027)
7.3.3 Europe Deep Vein Thrombosis (DVT) Drug Market Size by Application (2016-2027)
7.4 Europe Deep Vein Thrombosis (DVT) Drug Market Size by Country
7.4.1 Europe Deep Vein Thrombosis (DVT) Drug Market Size by Country (2016-2021)
7.4.2 Europe Deep Vein Thrombosis (DVT) Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size (2016-2027)
8.2 Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size by Type
8.2.1 Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size by Application
8.3.1 Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size by Region
8.4.1 Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Deep Vein Thrombosis (DVT) Drug Market Size (2016-2027)
9.2 Latin America Deep Vein Thrombosis (DVT) Drug Market Size by Type
9.2.1 Latin America Deep Vein Thrombosis (DVT) Drug Market Size by Type (2016-2021)
9.2.2 Latin America Deep Vein Thrombosis (DVT) Drug Market Size by Type (2022-2027)
9.2.3 Latin America Deep Vein Thrombosis (DVT) Drug Market Size by Type (2016-2027)
9.3 Latin America Deep Vein Thrombosis (DVT) Drug Market Size by Application
9.3.1 Latin America Deep Vein Thrombosis (DVT) Drug Market Size by Application (2016-2021)
9.3.2 Latin America Deep Vein Thrombosis (DVT) Drug Market Size by Application (2022-2027)
9.3.3 Latin America Deep Vein Thrombosis (DVT) Drug Market Size by Application (2016-2027)
9.4 Latin America Deep Vein Thrombosis (DVT) Drug Market Size by Country
9.4.1 Latin America Deep Vein Thrombosis (DVT) Drug Market Size by Country (2016-2021)
9.4.2 Latin America Deep Vein Thrombosis (DVT) Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size (2016-2027)
10.2 Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size by Type
10.2.1 Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size by Application
10.3.1 Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size by Country
10.4.1 Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Deep Vein Thrombosis (DVT) Drug Introduction
11.1.4 Bayer Revenue in Deep Vein Thrombosis (DVT) Drug Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Deep Vein Thrombosis (DVT) Drug Introduction
11.2.4 Bristol-Myers Squibb Revenue in Deep Vein Thrombosis (DVT) Drug Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Deep Vein Thrombosis (DVT) Drug Introduction
11.3.4 Pfizer Revenue in Deep Vein Thrombosis (DVT) Drug Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Deep Vein Thrombosis (DVT) Drug Introduction
11.4.4 Sanofi Revenue in Deep Vein Thrombosis (DVT) Drug Business (2016-2021)
11.4.5 Sanofi Recent Development
11.5 GSK
11.5.1 GSK Company Details
11.5.2 GSK Business Overview
11.5.3 GSK Deep Vein Thrombosis (DVT) Drug Introduction
11.5.4 GSK Revenue in Deep Vein Thrombosis (DVT) Drug Business (2016-2021)
11.5.5 GSK Recent Development
11.6 Daiichi Sankyo
11.6.1 Daiichi Sankyo Company Details
11.6.2 Daiichi Sankyo Business Overview
11.6.3 Daiichi Sankyo Deep Vein Thrombosis (DVT) Drug Introduction
11.6.4 Daiichi Sankyo Revenue in Deep Vein Thrombosis (DVT) Drug Business (2016-2021)
11.6.5 Daiichi Sankyo Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Deep Vein Thrombosis (DVT) Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Blood Thinners
Table 3. Key Players of Tissue Plasminogen Activators
Table 4. Key Players of Other Drug
Table 5. Global Deep Vein Thrombosis (DVT) Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Deep Vein Thrombosis (DVT) Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Deep Vein Thrombosis (DVT) Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Deep Vein Thrombosis (DVT) Drug Market Share by Regions (2016-2021)
Table 9. Global Deep Vein Thrombosis (DVT) Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Deep Vein Thrombosis (DVT) Drug Market Share by Regions (2022-2027)
Table 11. Deep Vein Thrombosis (DVT) Drug Market Trends
Table 12. Deep Vein Thrombosis (DVT) Drug Market Drivers
Table 13. Deep Vein Thrombosis (DVT) Drug Market Challenges
Table 14. Deep Vein Thrombosis (DVT) Drug Market Restraints
Table 15. Global Deep Vein Thrombosis (DVT) Drug Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Deep Vein Thrombosis (DVT) Drug Market Share by Players (2016-2021)
Table 17. Global Top Deep Vein Thrombosis (DVT) Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Deep Vein Thrombosis (DVT) Drug as of 2020)
Table 18. Ranking of Global Top Deep Vein Thrombosis (DVT) Drug Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Deep Vein Thrombosis (DVT) Drug Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Deep Vein Thrombosis (DVT) Drug Product Solution and Service
Table 22. Date of Enter into Deep Vein Thrombosis (DVT) Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Deep Vein Thrombosis (DVT) Drug Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Deep Vein Thrombosis (DVT) Drug Revenue Market Share by Type (2016-2021)
Table 26. Global Deep Vein Thrombosis (DVT) Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Deep Vein Thrombosis (DVT) Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Deep Vein Thrombosis (DVT) Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Deep Vein Thrombosis (DVT) Drug Revenue Market Share by Application (2016-2021)
Table 30. Global Deep Vein Thrombosis (DVT) Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Deep Vein Thrombosis (DVT) Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Deep Vein Thrombosis (DVT) Drug Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Deep Vein Thrombosis (DVT) Drug Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Deep Vein Thrombosis (DVT) Drug Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Deep Vein Thrombosis (DVT) Drug Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Deep Vein Thrombosis (DVT) Drug Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Deep Vein Thrombosis (DVT) Drug Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Deep Vein Thrombosis (DVT) Drug Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Deep Vein Thrombosis (DVT) Drug Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Deep Vein Thrombosis (DVT) Drug Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Deep Vein Thrombosis (DVT) Drug Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Deep Vein Thrombosis (DVT) Drug Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Deep Vein Thrombosis (DVT) Drug Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Deep Vein Thrombosis (DVT) Drug Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Deep Vein Thrombosis (DVT) Drug Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Deep Vein Thrombosis (DVT) Drug Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Deep Vein Thrombosis (DVT) Drug Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Deep Vein Thrombosis (DVT) Drug Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Deep Vein Thrombosis (DVT) Drug Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bayer Company Details
Table 63. Bayer Business Overview
Table 64. Bayer Deep Vein Thrombosis (DVT) Drug Product
Table 65. Bayer Revenue in Deep Vein Thrombosis (DVT) Drug Business (2016-2021) & (US$ Million)
Table 66. Bayer Recent Development
Table 67. Bristol-Myers Squibb Company Details
Table 68. Bristol-Myers Squibb Business Overview
Table 69. Bristol-Myers Squibb Deep Vein Thrombosis (DVT) Drug Product
Table 70. Bristol-Myers Squibb Revenue in Deep Vein Thrombosis (DVT) Drug Business (2016-2021) & (US$ Million)
Table 71. Bristol-Myers Squibb Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Deep Vein Thrombosis (DVT) Drug Product
Table 75. Pfizer Revenue in Deep Vein Thrombosis (DVT) Drug Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Sanofi Company Details
Table 78. Sanofi Business Overview
Table 79. Sanofi Deep Vein Thrombosis (DVT) Drug Product
Table 80. Sanofi Revenue in Deep Vein Thrombosis (DVT) Drug Business (2016-2021) & (US$ Million)
Table 81. Sanofi Recent Development
Table 82. GSK Company Details
Table 83. GSK Business Overview
Table 84. GSK Deep Vein Thrombosis (DVT) Drug Product
Table 85. GSK Revenue in Deep Vein Thrombosis (DVT) Drug Business (2016-2021) & (US$ Million)
Table 86. GSK Recent Development
Table 87. Daiichi Sankyo Company Details
Table 88. Daiichi Sankyo Business Overview
Table 89. Daiichi Sankyo Deep Vein Thrombosis (DVT) Drug Product
Table 90. Daiichi Sankyo Revenue in Deep Vein Thrombosis (DVT) Drug Business (2016-2021) & (US$ Million)
Table 91. Daiichi Sankyo Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Deep Vein Thrombosis (DVT) Drug Market Share by Type: 2020 VS 2027
Figure 2. Blood Thinners Features
Figure 3. Tissue Plasminogen Activators Features
Figure 4. Other Drug Features
Figure 5. Global Deep Vein Thrombosis (DVT) Drug Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Drug Stores Case Studies
Figure 9. Deep Vein Thrombosis (DVT) Drug Report Years Considered
Figure 10. Global Deep Vein Thrombosis (DVT) Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Deep Vein Thrombosis (DVT) Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Deep Vein Thrombosis (DVT) Drug Market Share by Regions: 2020 VS 2027
Figure 13. Global Deep Vein Thrombosis (DVT) Drug Market Share by Regions (2022-2027)
Figure 14. Global Deep Vein Thrombosis (DVT) Drug Market Share by Players in 2020
Figure 15. Global Top Deep Vein Thrombosis (DVT) Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Deep Vein Thrombosis (DVT) Drug as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Deep Vein Thrombosis (DVT) Drug Revenue in 2020
Figure 17. Global Deep Vein Thrombosis (DVT) Drug Revenue Market Share by Type (2016-2021)
Figure 18. Global Deep Vein Thrombosis (DVT) Drug Revenue Market Share by Type (2022-2027)
Figure 19. North America Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Deep Vein Thrombosis (DVT) Drug Market Share by Type (2016-2027)
Figure 21. North America Deep Vein Thrombosis (DVT) Drug Market Share by Application (2016-2027)
Figure 22. North America Deep Vein Thrombosis (DVT) Drug Market Share by Country (2016-2027)
Figure 23. United States Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Deep Vein Thrombosis (DVT) Drug Market Share by Type (2016-2027)
Figure 27. Europe Deep Vein Thrombosis (DVT) Drug Market Share by Application (2016-2027)
Figure 28. Europe Deep Vein Thrombosis (DVT) Drug Market Share by Country (2016-2027)
Figure 29. Germany Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Deep Vein Thrombosis (DVT) Drug Market Share by Region (2016-2027)
Figure 39. China Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Deep Vein Thrombosis (DVT) Drug Market Share by Type (2016-2027)
Figure 47. Latin America Deep Vein Thrombosis (DVT) Drug Market Share by Application (2016-2027)
Figure 48. Latin America Deep Vein Thrombosis (DVT) Drug Market Share by Country (2016-2027)
Figure 49. Mexico Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Deep Vein Thrombosis (DVT) Drug Market Share by Country (2016-2027)
Figure 55. Turkey Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Bayer Revenue Growth Rate in Deep Vein Thrombosis (DVT) Drug Business (2016-2021)
Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Deep Vein Thrombosis (DVT) Drug Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Deep Vein Thrombosis (DVT) Drug Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Deep Vein Thrombosis (DVT) Drug Business (2016-2021)
Figure 62. GSK Revenue Growth Rate in Deep Vein Thrombosis (DVT) Drug Business (2016-2021)
Figure 63. Daiichi Sankyo Revenue Growth Rate in Deep Vein Thrombosis (DVT) Drug Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---